ESAIC focused guideline for the use of cardiac biomarkers in perioperative risk evaluation

BACKGROUND In recent years, there has been increasing focus on the use of cardiac biomarkers in patients undergoing noncardiac surgery. AIMS The aim of this focused guideline was to provide updated guidance regarding the pre-, post- and combined pre-and postoperative use of cardiac troponin and B-type natriuretic peptides in adult patients undergoing noncardiac surgery. METHODS The guidelines were prepared using Grading of Recommendations Assessment Development and Evaluation (GRADE) methodology. This included the definition of critical outcomes, a systematic literature search, appraisal of certainty of evidence, evaluation of biomarker measurement in terms of the balance of desirable and undesirable effects including clinical outcomes, resource use, health inequality, stakeholder acceptance, and implementation. The panel differentiated between three different scopes of applications: cardiac biomarkers as prognostic factors, as tools for risk prediction, and for biomarker-enhanced management strategies. RESULTS In a modified Delphi process, the task force defined 12 critical outcomes. The systematic literature search resulted in over 25,000 hits, of which 115 full-text articles formed the body of evidence for recommendations. The evidence appraisal indicated heterogeneity in the certainty of evidence across critical outcomes. Further, there was relevant gradient in the certainty of evidence across the three scopes of application. Recommendations were issued and if this was not possible due to limited evidence, clinical practice statements were produced. CONCLUSION The ESAIC focused guidelines provide guidance on the perioperative use of cardiac troponin and B-type natriuretic peptides in patients undergoing noncardiac surgery, for three different scopes of application. GRAPHICAL ABSTRACT http://links.lww.com/EJA/A845.

[1]  P. Kavsak.  The PROVE-HF Study: Additional Proof for the Inclusion of the Manufacturer's Name When Reporting B-Type Natriuretic Peptide Results. , 2022, Clinical chemistry.

[2]  D. Atar,et al.  2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. , 2022, European heart journal.

[3]  Minghui Yang,et al.  Association of Acute Perioperative Myocardial Injury With All-Cause Mortality Within 90 Days After Hip Fracture Repair in the Elderly: A Prospective Study , 2022, Geriatric orthopaedic surgery & rehabilitation.

[4]  M. Fredrikson,et al.  Identification of myocardial injury using perioperative troponin surveillance in major noncardiac surgery and net benefit over the Revised Cardiac Risk Index. , 2021, British journal of anaesthesia.

[5]  D. Milic,et al.  Predictive potential of biomarkers and risk scores for major adverse cardiac events in elderly patients undergoing major elective vascular surgery. , 2021, Reviews in cardiovascular medicine.

[6]  Kyunga Kim,et al.  Association between cardiologist evaluation and mortality in myocardial injury after non-cardiac surgery , 2021, Heart.

[7]  L. Steiner,et al.  Incidence and outcomes of perioperative myocardial infarction/injury diagnosed by high-sensitivity cardiac troponin I , 2021, Clinical Research in Cardiology.

[8]  M. Baltatzis,et al.  Elevation of High-sensitive Troponin T Predicts Mortality After Open Pancreaticoduodenectomy , 2021, World Journal of Surgery.

[9]  P. Devereaux,et al.  Misclassification of myocardial injury by a high-sensitivity cardiac troponin I assay. , 2021, The Canadian journal of cardiology.

[10]  Pavel S. Roshanov,et al.  Preoperative levels of natriuretic peptides and the incidence of postoperative atrial fibrillation after noncardiac surgery: a prospective cohort study , 2020, Canadian Medical Association Journal.

[11]  L. Steiner,et al.  Etiology of Peri-Operative Myocardial Infarction/Injury After Noncardiac Surgery and Associated Outcome. , 2020, Journal of the American College of Cardiology.

[12]  Jeong Hoon Yang,et al.  Preoperative cardiac troponin below the 99th-percentile upper reference limit and 30-day mortality after noncardiac surgery , 2020, Scientific Reports.

[13]  Kyunga Kim,et al.  Postoperative statin treatment may be associated with improved mortality in patients with myocardial injury after noncardiac surgery , 2020, Scientific Reports.

[14]  Kyunga Kim,et al.  Comparison of acute and chronic myocardial injury in noncardiac surgical patients , 2020, PloS one.

[15]  J. Krisam,et al.  Presepsin (sCD14-ST) for pre-operative prediction of major adverse cardiovascular events in coronary heart disease patients undergoing noncardiac surgery: Post hoc analysis of the Leukocytes and Cardiovascular Peri-operative Events-2 (LeukoCAPE-2) Study. , 2020, European journal of anaesthesiology.

[16]  J. Burcharth,et al.  The risk of post‐operative myocardial injury after major emergency abdominal surgery: A retrospective cohort study , 2020, Acta anaesthesiologica Scandinavica.

[17]  J. Galindo-Uribe,et al.  EVALUATION OF PERIOPERATIVE HIGH-SENSITIVE CARDIAC TROPONIN I AS A PREDICTIVE BIOMARKER OF MAJOR ADVERSE CARDIOVASCULAR EVENTS AFTER NONCARDIAC SURGERY. , 2020, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

[18]  A. Herrera,et al.  Risk factors for major adverse cardiovascular events after osteoporotic hip fracture repair surgery. , 2020, Injury.

[19]  R. Pearse,et al.  Early elevation in plasma high-sensitivity troponin T and morbidity after elective noncardiac surgery: prospective multicentre observational cohort study. , 2020, British journal of anaesthesia.

[20]  B. Caramelli,et al.  Troponin I as a mortality marker after lung resection surgery – a prospective cohort study , 2020, BMC Anesthesiology.

[21]  G. Guyatt,et al.  Preoperative N-Terminal Pro–B-Type Natriuretic Peptide and Cardiovascular Events After Noncardiac Surgery , 2019, Annals of Internal Medicine.

[22]  A. Dart,et al.  Preoperative biomarker evaluation for the prediction of cardiovascular events after major vascular surgery. , 2019, Journal of vascular surgery.

[23]  David R. Jones,et al.  A brain natriuretic peptide-based prediction model for atrial fibrillation after thoracic surgery: Development and internal validation. , 2019, The Journal of thoracic and cardiovascular surgery.

[24]  N. L. Vuong,et al.  NT-proBNP incorporated in prediction rule of major peri-operative adverse cardiac event in non-cardiac surgery. , 2019, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.

[25]  R. Stolker,et al.  Postoperative troponin release is associated with major adverse cardiovascular events in the first year after noncardiac surgery. , 2019, International journal of cardiology.

[26]  Xi-wen Wang,et al.  Risk factors of atrial fibrillation occurring after radical surgery of esophageal carcinoma , 2019, Journal of Cardiothoracic Surgery.

[27]  E. Klein,et al.  Perioperative Troponin is a Predictor of Both Short- and Intermediate-term Mortality Among Patients Undergoing Major Urologic Surgery. , 2018, Urology.

[28]  D. Milic,et al.  Potential New Approaches in Predicting Adverse Cardiac Events One Month after Major Vascular Surgery , 2018, Medical Principles and Practice.

[29]  M. Licker,et al.  Patient and procedural features predicting early and mid-term outcome after radical surgery for non-small cell lung cancer. , 2018, Journal of thoracic disease.

[30]  A. Jaffe,et al.  Comparison of high‐sensitivity cardiac troponin I and T for the prediction of cardiac complications after non‐cardiac surgery , 2018, American heart journal.

[31]  Fulong Zhao,et al.  Analysis of risk factors for perioperative mortality in elderly patients with intertrochanteric fracture , 2018, European Journal of Orthopaedic Surgery & Traumatology.

[32]  G. Guyatt,et al.  Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial , 2018, The Lancet.

[33]  Lynn V. Andrews,et al.  Assessment of functional capacity before major non-cardiac surgery: an international, prospective cohort study , 2018, The Lancet.

[34]  G. Bettelli,et al.  Pre-operative evaluation of adults undergoing elective noncardiac surgery: Updated guideline from the European Society of Anaesthesiology. , 2018, European journal of anaesthesiology.

[35]  V. Menon,et al.  Myocardial injury after noncardiac surgery—incidence and predictors from a prospective observational cohort study at an Indian tertiary care centre , 2018, Medicine.

[36]  Zheng-Song Gu,et al.  Postoperative Adverse Cardiovascular Events Associated with Leptin and Adverse Age After Elective Major Non-Cardiac Surgery: An Asian Single-Center Study , 2018, Medical science monitor : international medical journal of experimental and clinical research.

[37]  K. Leslie,et al.  Implication of Major Adverse Postoperative Events and Myocardial Injury on Disability and Survival: A Planned Subanalysis of the ENIGMA-II Trial , 2018, Anesthesia and analgesia.

[38]  J. Oh,et al.  Association between preoperative high sensitive troponin I levels and cardiovascular events after hip fracture surgery in the elderly , 2018, Journal of geriatric cardiology : JGC.

[39]  Jayoun Kim,et al.  Prognostic Role of High-sensitivity Cardiac Troponin I and Soluble Suppression of Tumorigenicity-2 in Surgical Intensive Care Unit Patients Undergoing Non-cardiac Surgery , 2018, Annals of laboratory medicine.

[40]  Zhi-yong Liu,et al.  B-type Natriuretic Peptide and Other Risk Factors for Predicting Postoperative Atrial Fibrillation after Thoracic Surgery , 2017, The Thoracic and Cardiovascular Surgeon.

[41]  M. Seeberger,et al.  Perioperative Myocardial Injury After Noncardiac Surgery: Incidence, Mortality, and Characterization , 2017, Circulation.

[42]  V. Deltuva,et al.  Preoperative N-terminal pro-B-type natriuretic peptide concertation and prognosis of brain tumor patients: a 5-year follow up study , 2017, Scientific Reports.

[43]  D. Farmakis,et al.  Cardiac Biomarkers Predict 1-Year Mortality in Elderly Patients Undergoing Hip Fracture Surgery. , 2017, Orthopedics.

[44]  B. Biccard,et al.  Incidence and hospital mortality of vascular surgery patients with perioperative myocardial infarction (PMI) or myocardial injury after non-cardiac surgery (MINS) , 2017 .

[45]  Pavel S. Roshanov,et al.  Association of Postoperative High-Sensitivity Troponin Levels With Myocardial Injury and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery , 2017, JAMA.

[46]  H. Nathoe,et al.  Kinetics of troponin I in patients with myocardial injury after noncardiac surgery , 2017, Clinical chemistry and laboratory medicine.

[47]  A. Jaffe,et al.  Improving Prediction of Postoperative Myocardial Infarction With High-Sensitivity Cardiac Troponin T and NT-proBNP , 2017, Anesthesia and analgesia.

[48]  D. Suzuki,et al.  Does N-terminal Pro-brain Type Natriuretic Peptide Predict Cardiac Complications After Hip Fracture Surgery? , 2017, Clinical orthopaedics and related research.

[49]  D. Sessler,et al.  Troponin Elevation After Colorectal Surgery: Significance and Management , 2016, Annals of surgery.

[50]  J. Sung,et al.  Prognostic value of preoperative N‐terminal pro‐brain natriuretic peptide in non‐cardiac surgery of elderly patients with normal left ventricular systolic function , 2016, Geriatrics & gerontology international.

[51]  D. Heffernan,et al.  Preoperative Myocardial Injury as a Predictor of Mortality in Emergency General Surgery: An Analysis Using the American College of Surgeons NSQIP Database. , 2016, Journal of the American College of Surgeons.

[52]  H. Nathoe,et al.  One-Year Mortality, Causes of Death, and Cardiac Interventions in Patients with Postoperative Myocardial Injury , 2016, Anesthesia and analgesia.

[53]  E. Jewell,et al.  Timing of Preoperative Troponin Elevations and Postoperative Mortality After Noncardiac Surgery , 2016, Anesthesia and analgesia.

[54]  Melissa C Brouwers,et al.  The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines , 2016, British Medical Journal.

[55]  M. Radford,et al.  Relation of perioperative elevation of troponin to long-term mortality after orthopedic surgery. , 2015, The American journal of cardiology.

[56]  G. Filippatos,et al.  B-type natriuretic peptide vs. cardiac risk scores for prediction of outcome following major orthopedic surgery , 2015, Journal of cardiovascular medicine.

[57]  E. P. Dongen,et al.  High-sensitive cardiac troponin T measurements in prediction of non-cardiac complications after major abdominal surgery. , 2015, British journal of anaesthesia.

[58]  Yutang Wang,et al.  Prediction of Perioperative Cardiac Events through Preoperative NT-pro-BNP and cTnI after Emergent Non-Cardiac Surgery in Elderly Patients , 2015, PloS one.

[59]  B. Walder,et al.  Minimal clinically important difference: a novel approach to measure changes in outcome in perioperative medicine. , 2015, European journal of anaesthesiology.

[60]  M. Okumura,et al.  B-Type Natriuretic Peptide-Guided Risk Assessment for Postoperative Complications in Lung Cancer Surgery , 2015, World Journal of Surgery.

[61]  S. Davies,et al.  Early cardiology assessment and intervention reduces mortality following myocardial injury after non-cardiac surgery (MINS). , 2014, Journal of thoracic disease.

[62]  P. Coriat,et al.  The Long-Term Impact of Early Cardiovascular Therapy Intensification for Postoperative Troponin Elevation After Major Vascular Surgery , 2014, Anesthesia and analgesia.

[63]  R. Rodseth,et al.  B-type natriuretic peptide following thoracic surgery: a predictor of postoperative cardiopulmonary complications. , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[64]  A. Passantino,et al.  Combined use of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for risk stratification of vascular surgery patients. , 2014, Annals of vascular surgery.

[65]  A. Großhennig,et al.  Perioperative Levels and Changes of High-Sensitivity Troponin T Are Associated With Cardiovascular Events in Vascular Surgery Patients* , 2014, Critical care medicine.

[66]  E. Herrmann,et al.  Elevated cardiac troponin T is associated with higher mortality and amputation rates in patients with peripheral arterial disease. , 2014, Journal of the American College of Cardiology.

[67]  P. J. Devereaux,et al.  The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N-terminal fragment of pro-B-type natriuretic peptide: a systematic review and individual patient data meta-analysis. , 2014, Journal of the American College of Cardiology.

[68]  C. Polanczyk,et al.  Clinical Use of Ultrasensitive Cardiac Troponin I Assay in Intermediate- and High-Risk Surgery Patients , 2013, Disease markers.

[69]  H. Nathoe,et al.  Myocardial Injury After Noncardiac Surgery and its Association With Short-Term Mortality , 2013, Circulation.

[70]  C. Andersen,et al.  Application of preoperative brain natriuretic peptide levels in clinical practice , 2013, Vascular.

[71]  C. Polanczyk,et al.  Prognostic value of perioperative N-terminal pro-B-type natriuretic peptide in noncardiac surgery. , 2013, Arquivos brasileiros de cardiologia.

[72]  P. Rehak,et al.  Role of N-terminal pro B-type natriuretic peptide in identifying patients at high risk for adverse outcome after emergent non-cardiac surgery. , 2013, British journal of anaesthesia.

[73]  M. Seeberger,et al.  Incremental value of high-sensitive troponin T in addition to the revised cardiac index for peri-operative risk stratification in non-cardiac surgery. , 2013, European heart journal.

[74]  J. McClure,et al.  B-type natriuretic peptide predicts postoperative cardiac events and mortality after elective open abdominal aortic aneurysm repair. , 2013, Journal of vascular surgery.

[75]  M. Farkouh,et al.  Use of clinically based troponin underestimates the cardiac injury in non-cardiac surgery: a single-centre cohort study in 51,701 consecutive patients , 2012, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.

[76]  J. Oh,et al.  Plasma N-Terminal Pro-B-Type Natriuretic Peptide Is Predictive of Perioperative Cardiac Events in Patients Undergoing Vascular Surgery , 2012, The Korean journal of internal medicine.

[77]  S. Bagshaw,et al.  Elevated cardiac troponin in the early post-operative period and mortality following ruptured abdominal aortic aneurysm: a retrospective population-based cohort study , 2012, Critical Care.

[78]  Gary S Collins,et al.  Interpreting diagnostic accuracy studies for patient care , 2012, BMJ : British Medical Journal.

[79]  J. Savige,et al.  Does cardiology intervention improve mortality for post-operative troponin elevations after emergency orthopaedic-geriatric surgery? A randomised controlled study. , 2012, Injury.

[80]  J. Savige,et al.  N-terminal pro-brain natriuretic peptide and angiotensin-converting enzyme-2 levels and their association with postoperative cardiac complications after emergency orthopedic surgery. , 2012, The American journal of cardiology.

[81]  B. Biccard,et al.  What is the best pre‐operative risk stratification tool for major adverse cardiac events following elective vascular surgery? A prospective observational cohort study evaluating pre‐operative myocardial ischaemia monitoring and biomarker analysis , 2012, Anaesthesia.

[82]  G. Guyatt,et al.  Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. , 2012, JAMA.

[83]  S. Garcia,et al.  Peak postoperative troponin levels outperform preoperative cardiac risk indices as predictors of long-term mortality after vascular surgery Troponins and postoperative outcomes. , 2012, Journal of critical care.

[84]  E. Spitznagel,et al.  Postoperative myocardial injury after major head and neck cancer surgery , 2011, Head & neck.

[85]  C. Berry,et al.  B-type natriuretic peptide predicts long-term survival after major non-cardiac surgery. , 2011, British journal of anaesthesia.

[86]  I. Park,et al.  N-Terminal Pro-B-type Natriuretic Peptide Is Useful to Predict Cardiac Complications Following Lung Resection Surgery , 2011, The Korean journal of thoracic and cardiovascular surgery.

[87]  Jeroen J. Bax,et al.  Predictive Value of NT-proBNP in Vascular Surgery Patients with COPD and Normal Left Ventricular Systolic Function , 2011, COPD.

[88]  F. Nogueira,et al.  B-type natriuretic peptide is predictive of postoperative events in orthopedic surgery. , 2010, Arquivos brasileiros de cardiologia.

[89]  J. Savige,et al.  Usefulness of N-terminal pro-brain natriuretic peptide to predict postoperative cardiac complications and long-term mortality after emergency lower limb orthopedic surgery. , 2010, The American journal of cardiology.

[90]  C. Schindler,et al.  B-type natriuretic peptide in patients undergoing orthopaedic surgery: a prospective cohort study , 2010, European journal of anaesthesiology.

[91]  M. Okumura,et al.  Predictive value of B-type natriuretic peptide for postoperative atrial fibrillation following pulmonary resection for lung cancer. , 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[92]  N. Obuchowski,et al.  Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures , 2010, Epidemiology.

[93]  Jeroen J. Bax,et al.  The Interrelationship Between Preoperative Anemia and N-Terminal Pro-B-Type Natriuretic Peptide: The Effect on Predicting Postoperative Cardiac Outcome in Vascular Surgery Patients , 2009, Anesthesia and analgesia.

[94]  D. Cho,et al.  Preoperative NT-proBNP and CRP predict perioperative major cardiovascular events in non-cardiac surgery , 2009, Heart.

[95]  M. Fredrikson,et al.  Predictors of cardiac events in high‐risk patients undergoing emergency surgery , 2009, Acta anaesthesiologica Scandinavica.

[96]  Jeroen J. Bax,et al.  Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients , 2009, Coronary artery disease.

[97]  M. Seeberger,et al.  A Preliminary Report on the Prognostic Significance of Preoperative Brain Natriuretic Peptide and Postoperative Cardiac Troponin in Patients Undergoing Major Vascular Surgery , 2009, Anesthesia and analgesia.

[98]  Jeroen J. Bax,et al.  Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery. , 2009, Journal of vascular surgery.

[99]  W. Lim,et al.  Incidence of post-operative troponin I rises and 1-year mortality after emergency orthopaedic surgery in older patients. , 2008, Age and ageing.

[100]  D. Benhamou,et al.  Cardiac troponin I release after hip surgery correlates with poor long‐term cardiac outcome , 2008, European journal of anaesthesiology.

[101]  M. Jeong,et al.  Preoperative plasma N-terminal pro-brain natriuretic peptide concentration and perioperative cardiovascular risk in elderly patients. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[102]  W. Srikusalanukul,et al.  Elevated serum cardiac troponin I in older patients with hip fracture: incidence and prognostic significance , 2008, Archives of Orthopaedic and Trauma Surgery.

[103]  G. Hillis,et al.  Utility of B-type natriuretic peptide in predicting perioperative cardiac events in patients undergoing major non-cardiac surgery. , 2007, British journal of anaesthesia.

[104]  P. Rehak,et al.  N-Terminal Pro-brain Natriuretic Peptide Identifies Patients at High Risk for Adverse Cardiac Outcome after Vascular Surgery , 2007, Anesthesiology.

[105]  G. Veronesi,et al.  Increased Perioperative N-Terminal Pro-B-Type Natriuretic Peptide Levels Predict Atrial Fibrillation After Thoracic Surgery for Lung Cancer , 2007, Circulation.

[106]  Jeroen J. Bax,et al.  Association of plasma N-terminal pro-B-type natriuretic peptide with postoperative cardiac events in patients undergoing surgery for abdominal aortic aneurysm or leg bypass. , 2006, The American journal of cardiology.

[107]  J. Dernellis,et al.  Assessment of cardiac risk before non-cardiac surgery: brain natriuretic peptide in 1590 patients , 2006, Heart.

[108]  Jeroen J. Bax,et al.  Plasma N-Terminal Pro-B-Type Natriuretic Peptide as a Long-Term Prognostic Marker After Major Vascular Surgery , 2007, Journal of Vascular Surgery.

[109]  A. Jaffe,et al.  Vascular surgery patients: perioperative and long-term risk according to the ACC/AHA guidelines, the additive role of post-operative troponin elevation. , 2005, European heart journal.

[110]  C. Berry,et al.  Predictive value of plasma brain natriuretic peptide for cardiac outcome after vascular surgery , 2005, Heart.

[111]  A. Perel,et al.  Early and Delayed Myocardial Infarction after Abdominal Aortic Surgery , 2005, Anesthesiology.

[112]  Peter J. Pronovost,et al.  Cardiac Troponin I Predicts Short-Term Mortality in Vascular Surgery Patients , 2002, Circulation.

[113]  C. Baillard,et al.  Cardiac troponin I is reliable with immediate but not medium‐term cardiac complications after abdominal aortic repair , 2000, Acta anaesthesiologica Scandinavica.

[114]  E. Cook,et al.  Prognostic value of cardiac troponin T after noncardiac surgery: 6-month follow-up data. , 1997, Journal of the American College of Cardiology.

[115]  Arsal Acarbaş.  Value of N-terminal Pro-brain Natriuretic Peptide in Predicting Perioperative Complications Following Spinal Surgery. , 2019, World neurosurgery.

[116]  R. Stolker,et al.  Prognostic value of postoperative high‐sensitivity troponin T in patients with different stages of kidney disease undergoing noncardiac surgery , 2018, British journal of anaesthesia.

[117]  F. Ramasco Rueda,et al.  High levels of preoperative and postoperative N terminal B-type natriuretic propeptide influence mortality and cardiovascular complications after noncardiac surgery: A prospective cohort study. , 2016, European journal of anaesthesiology.

[118]  N. Petrucciani,et al.  Preoperative Brain Natriuretic Peptide (BNP) Is a Better Predictor of Adverse Cardiac Events Compared to Preoperative Scoring System in Patients Who Underwent Abdominal Surgery , 2011, World Journal of Surgery.

[119]  Jeroen J. Bax,et al.  Influence of renal function on the usefulness of N-terminal pro-B-type natriuretic peptide as a prognostic cardiac risk marker in patients undergoing noncardiac vascular surgery. , 2008, The American journal of cardiology.